Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • State of the Art
  • Published:

State-of-the-Art

Strategies for prevention of RSV nosocomial infection

Abstract

Objective:

To review the literature on respiratory syncytial virus (RSV) as a cause of nosocomial infections (NI) on neonatal intensive care units (NICUs) and pediatric wards, and the effectiveness of various containment strategies.

Study Design:

We conducted a literature review to define characteristics of RSV NI, and to evaluate the relative effectiveness of various infection containment programs, including the use of palivizumab on the reported incidence of RSV NI on NICUs and pediatric wards.

Result:

Highly variable rates of RSV NI have not significantly changed since RSV was first identified. The evaluation of the effectiveness of containment strategies has relied on before/after study designs. Focus on rapid patient diagnosis, compliance of acceptable handwashing techniques and cohorting of patients and staff appears to form the backbone of most prevention and containment programs. When these or other measures have failed, the administration of palivizumab has been useful in halting the spread of RSV NI in children.

Conclusion:

RSV NI continues to be prevalent in the NICU despite adoption of infection control programs. Preventive measures should be employed to lower the risk of RSV NI and, if identified, appropriate containment strategies should be rapidly implemented.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Glezen WP, Taber LH, Frank AL, Kasel JA . Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543–546.

    CAS  PubMed  Google Scholar 

  2. Morris J, Blount RE, Savage RE . Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med 1956; 92: 544–550.

    Article  Google Scholar 

  3. Kapikian AZ, Bell JA, Mastrota FM, Johnson KM, Huebner RJ, Chanock RM . An outbreak of febrile illness and pneumonia associated with respiratory syncytial virus infection. Am J Hyg 1961; 74: 234–248.

    CAS  PubMed  Google Scholar 

  4. Berkovich S . Acute respiratory illness in the premature nursery associated with respiratory syncytial virus infections. Pediatrics 1964; 34: 753–760.

    CAS  PubMed  Google Scholar 

  5. Welliver RC, McLaughlin S . Unique epidemiology of nosocomial infection in a children's hospital. AJDC 1984; 138: 131–135.

    CAS  PubMed  Google Scholar 

  6. Hall CB . Nosocomial respiratory syncytial virus infections: the ‘cold war’ has not ended. Clin Infect Dis 2000; 31: 590–596.

    Article  CAS  Google Scholar 

  7. Macartney KK, Gorelick MH, Manning ML, Hodinka RL, Bell LM . Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control. Pediatrics 2000; 106: 520–526.

    Article  CAS  Google Scholar 

  8. Berner R, Schwoerer F, Schumacher RF, Meder M, Forster J . Community and nosocomially acquired respiratory syncytial virus infection in a German paediatric hospital from 1988 to 1999. Eur J Pediatr 2001; 160: 541–547.

    Article  CAS  Google Scholar 

  9. Cooper ER, Harnisch BA, Fujii AM, Brown E, Appugliese D . RSV in the NICU: risk factors, spectrum of disease, and the role of routine surveillance in prevention of nosocomial infections. Pediatr Res 2004; 55: 336A.

    Google Scholar 

  10. Doherty JA, Brookfield DS, Gray J, McEwan RA . Cohorting of infants with respiratory syncytial virus. J Hosp Infect 1998; 38: 203–206.

    Article  CAS  Google Scholar 

  11. Gala CL, Hall CB, Schnabel KC, Pincus PH, Blossom P, Hildreth SW et al. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA 1986; 256: 2706–2708.

    Article  CAS  Google Scholar 

  12. Gouyon JB, Pothier P, Guignier F, Portier H, Pujol HP, Kazmierczak A et al. Outbreak of respiratory syncytial virus in France. Eur J Clin Microbiol 1985; 4: 415–416.

    Article  CAS  Google Scholar 

  13. Gustafson S . Investigation and control of an RSV cluster in a 26-bed level II/III nursery using electronic surveillance methods. Am J Infect Control 2005; 33: E125–E126.

    Article  Google Scholar 

  14. Halasa NB, Williams JV, Wilson GJ, Walsh WF, Schaffner W, Wright PF . Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 2005; 24: 1040–1044.

    Article  Google Scholar 

  15. Hall CB, Douglas RG, Geiman JM, Messner MK . Nosocomial respiratory syncytial virus infections. N Engl J Med 1975; 293: 1343–1346.

    Article  CAS  Google Scholar 

  16. Hall CB, Douglas RG . Nosocomial respiratory syncytial viral infections. Should gowns and masks be used? Am J Dis Child 1981; 135: 512–515.

    Article  CAS  Google Scholar 

  17. Hall CB, Geiman JM, Douglas RG, Meagher MP . Control of nosocomial respiratory syncytial viral infections. Pediatrics 1978; 62: 728–731.

    CAS  PubMed  Google Scholar 

  18. Hall CB, Kopelman AE, Douglas G, Geiman JM, Meagher MP . Neonatal respiratory syncytial virus infection. N Engl J Med 1979; 300: 393–396.

    Article  CAS  Google Scholar 

  19. Isaacs D, Dickson H, O'Callaghan C, Sheaves R, Winter A, Moxon ER . Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child 1991; 66: 227–231.

    Article  CAS  Google Scholar 

  20. Karanfil LV, Conlon M, Lykens K, Masters CF, Forman M, Griffith ME et al. Reducing the rate of nosocomially transmitted respiratory syncytial virus. Am J Infect Control 1999; 27: 91–96.

    Article  CAS  Google Scholar 

  21. Kilani RA . Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases. J Trop Pediatr 2002; 48: 118–122.

    Article  Google Scholar 

  22. Krasinski K, LaCouture R, Holtzman RS, Waithe E, Bonk S, Hanna B . Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr 1990; 116: 894–898.

    Article  CAS  Google Scholar 

  23. Langley JM, LeBlanc JC, Wang EEL, Law BJ, MacDonald NE, Mitchell I et al. Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a pediatric investigators collaborative network on infections in Canada study. Pediatrics 1997; 100: 943–946.

    Article  CAS  Google Scholar 

  24. Leclair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA . Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 1987; 317: 329–334.

    Article  CAS  Google Scholar 

  25. Madge P, Paton JY, McColl JH, Mackie PLK . Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992; 340: 1079–1083.

    Article  CAS  Google Scholar 

  26. Simon A, Khurana K, Wilkesmann A, Muller A, Engelhart S, Exner M et al. Nosocomial respiratory syncytial virus infection: impact of prospective surveillance and targeted infection control. Int J Hyg Environ Health 2006; 209: 317–324.

    Article  Google Scholar 

  27. Snydman DR, Greer C, Meissner HC, McIntosh K . Prevention of nosocomial transmission of respiratory syncytial virus in a newborn nursery. Infect Control Hosp Epidemiol 1988; 9: 105–108.

    Article  CAS  Google Scholar 

  28. Thorburn K, Kerr S, Taylor N, van Saene HKF . RSV outbreak in a paediatric intensive care unit. J Hosp Infect 2004; 57: 194–201.

    Article  CAS  Google Scholar 

  29. Vieira SE, Gilio AE, Miyao CR, Pahl MMC, Lotufo JPB, Hein N et al. Nosocomial respiratory syncytial virus infection in a pediatric ward. Infect Control Hosp Epidemiol 2003; 24: 468–469.

    Article  Google Scholar 

  30. Wilson CW, Stevenson DK, Arvin AM . A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery. Pediatr Infect Dis J 1989; 8: 24–29.

    Article  CAS  Google Scholar 

  31. Forster J, Schumacher RF . The clinical picture presented by premature neonates infected with the respiratory syncytial virus. Eur J Pediatr 1995; 154: 901–905.

    Article  CAS  Google Scholar 

  32. Krasinski K . Severe respiratory syncytial virus infection: clinical features, nosocomial acquisition and outcome. Pediatr Infect Dis 1985; 4: 250–257.

    Article  CAS  Google Scholar 

  33. Cox RA, Rao P, Brandon-Cox C . The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit. J Hosp Infect 2001; 48: 186–192.

    Article  CAS  Google Scholar 

  34. Heerens AT, Marshall DD, Bose CL . Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit. J Perinatol 2002; 22: 306–307.

    Article  Google Scholar 

  35. Valenti WM, Clarke TA, Hall CB, Menegus MA, Shapiro DL . Concurrent outbreaks of rhinovirus and respiratory syncytial virus in an intensive care nursery: epidemiology and associated risk factors. J Pediatr 1982; 100: 722–726.

    Article  CAS  Google Scholar 

  36. Okuonghae HO, Nwankwo MU, Okolo AA, Schuit KE . Nosocomial respiratory syncytial virus infection in a newborn nursery. Ann Trop Paediatr 1992; 12: 185–193.

    Article  CAS  Google Scholar 

  37. Hall CB, Douglas RG . Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99: 100–103.

    Article  CAS  Google Scholar 

  38. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R . Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53 (RR-3): 1–36.

    PubMed  Google Scholar 

  39. Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118: 1774–1793.

    Article  Google Scholar 

  40. Contreras PA, Sami IR, Darnell MER, Ottolini MG, Prince GA . Inactivation of a respiratory syncytial virus by generic hand dishwashing detergents and antibacterial hand soaps. Infect Control Hosp Epidemiol 1999; 20: 57–58.

    Article  CAS  Google Scholar 

  41. Conly JM, Hill S, Ross J, Ross J, Lertzman J, Louie TJ . Handwashing practices in an intensive care unit: the effects of an educational program and its relationship to infection rates. Am J Infect Control 1989; 17: 330–339.

    Article  CAS  Google Scholar 

  42. Goldman D, Larson E . Handwashing and nosocomial infections. N Engl J Med 1992; 327: 120–122.

    Article  Google Scholar 

  43. Pittet D, Mourouga P, Perneger TV . Compliance with handwashing in a teaching hospital. Ann Intern Med 1999; 130: 126–130.

    Article  CAS  Google Scholar 

  44. Sproat LJ, Inglis TJ . A multicenter survey of hand hygiene practice in intensive care units. J Hosp Infect 1994; 26: 137–148.

    Article  CAS  Google Scholar 

  45. Kang JO, Kim CR . Nosocomial respiratory syncytial virus infection in a newborn nursery. J Korean Med Sci 1997; 12: 489–491.

    Article  CAS  Google Scholar 

  46. Feltes TF, Cabalka AK, Miessner C, Piazza FM, Carlin DA, Top HF et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 2003; 143: 532–540.

    Article  CAS  Google Scholar 

  47. Heerens AT, Marshall DD, Bose CL . Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit. J Perinatol 2002; 22: 306–307.

    Article  Google Scholar 

  48. Salcedo S, Vinzo J, Calico I, Campins M, Castillo F, Perapoch J et al. Administration of palivizumab (monoclonal antibodies against respiratory syncytial virus) during a nosocomial outbreak in a neonatal unit. Prenatal Neonatal Med 2000; 5 (Suppl 2): 180.

    Google Scholar 

  49. Abadesso C, Almeida HI, Virella D, Carreiro MH, Machado MC . Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit. J Hosp Infect 2004; 58: 38–41.

    Article  CAS  Google Scholar 

  50. Mejias A, Chavez-Bueno S, Sanchez PJ . Respiratory syncytial virus prophylaxis. NeoReviews 2005; 6: e26–e30.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Eggleston.

Additional information

Conflicts of Interest

Dr Groothuis, Dr Malinoski and Dr Eggleston have a proprietary interest in palivizumab, which is marketed by MedImmune Inc. Jay Bauman is a consultant to MedImmune and received financial support for data collection and analysis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Groothuis, J., Bauman, J., Malinoski, F. et al. Strategies for prevention of RSV nosocomial infection. J Perinatol 28, 319–323 (2008). https://doi.org/10.1038/jp.2008.37

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2008.37

Keywords

This article is cited by

Search

Quick links